Population | Subtypes | Marker | References |
---|---|---|---|
CAFs | – | α-SMA, vimentin, FAP, PDPN, PDGFRα/β, FSP1, DDR2, S100A4, CD10, GPR77 | |
MSCs | – | CD105+, CD73+, CD70+, CD13+, CD29+, CD44+, CD10+, CD45−, CD34−, CD14− or CD11b−, CD79a−, HLA-DR− | |
TAMs | M1 | CD68, CD11b, CD80, CD86 | |
M2 | CD68, CD11b, CD163, CD206 | ||
DCs | cDC1 | XCR1, CD45, CADM1, CLEC9A, CD141 | |
cDC2 | CD45, CD1C, FcεR1A, CD172A | ||
pDCs | CD45RA, CD123, CD2 | ||
Endothelial cells | – | PECAM1, CD31, CD34, CD13, CD29 | |
CD4+ T cells | – | CD3+CD4+CD8− | |
Th1 cells | CXCR3 | ||
Th2 cells | CCR4 | ||
Th17 cells | CCR6 | ||
Th22 cells | CCR10 | ||
Treg cells | CD4+CD25+Foxp3+ | ||
CD8+ T cells | - | CD3+ CD8+CD4− | |
Tc1 cells | CRCX3, IRF4 | ||
Tc2 cells | CCR4, CRTH2, GATA3 | ||
Tc9 cells | CRCX3, IRF4, IL9, IL10 | ||
Tc17 cells | CCR6, IL23R, IRF4, IL17 | ||
MDSCs | PMN-MDSCs | CD11b+CD33+HLA−DR−/CD14−CD15+ | |
M-MDSCs | CD11b+CD33+HLA−DR−/CD14+CD15− |